Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 4

2(50.0%)

N/A

1(25.0%)

Phase 1

1(25.0%)

4Total

Phase 4(2)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00638235Completed

Pelvic Floor Repair Systems for Prolapse Repair

Role: lead

NCT02121977Phase 4Terminated

Study of the Elevate Anterior and Apical Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse

Role: lead

NCT02123992Phase 4Terminated

Study of the Elevate Apical and Posterior Prolapse Repair System Compared to Native Tissue Repair for Pelvic Organ Prolapse

Role: lead

NCT01090739Not ApplicableCompleted

Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence

Role: lead

NCT00388947Completed

Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products

Role: lead

NCT01673360Terminated

Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices

Role: lead

NCT00565136Phase 1Completed

Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms

Role: lead

All 7 trials loaded